搜索
Search
Banner

熙华概况

About Xihua

Shanghai Xihua Scientific Co.,Ltd.(Xihua) was established in 2015. The headquarters is located in the core area of the Pharmaceutical Valley in Zhangjiang Hi-Tech Park, Shanghai. We have subsidiaries Xihua PharmaTech, Xihua Clinical , Suzhou Xihua, Xihua Pharmaceuticals, Chuzhou Xihua, etc. Besides, Xihua holds Primera Analytical Solutions Corp.(U.S.) and TCM Groups (U.S.) as well. With drug testing as the core, Xihua provides global pharmaceutical companies with high quality and efficient full process and integrated services from self-medicated development to market approval.

About Xihua

Our History

2015

2015

● Inception ● Establish small molecule bioanalysis platform
2016

2016

● Establish large molecule bioanalysis platform
2017

2017

● First NMPA inspection
2018

2018

● Establish Formulation Process Development platform ● Series A & B financing ● Zhoupu headquarters building was opened ● Recognized as a high-tech enterprise in Shanghai
2019

2019

● Establish data management & biostatistics platform
●  Received the award for Outstanding Enterprise in the Biopharmaceutical Industry at the China Innovation and    Entrepreneurship Competition
● Series C financing ● Participation in Primera Corporation
2020

2020

● Establish API Process Development platform ● Merged with Primera
● Appraised as the Specialized and Sophisticated SMEs in Shanghai
● Appraised as the R&D Institution in Pudong New Area ● Series D financing ● Completed shareholding reform
2021

2021

● Establish DMPK platform
2022

2022

● Merged with TCM ● Series E financing
2023

2023

● IPO filing

Choose Xihua

Providing integrated drug development services 

Reducing time costs;

Speeding up the R&D process;

Improving the success rate of drug development and shortening time to market for clients.

pic

International service capability

All core team members have rich experience;

With perfect quality assurance system;

Able to meet customers' needs for China-US dual declaration and global multi-center clinical declaration

pic

Leading technology advantage

Data as of June 30, 2022, it has passed more than 110 on-site inspections by national or local drug regulatory authorities and the FDA;

Equipped with a leading and abundant technology platform;

Actively laying out cutting-edge technologies with first-mover advantage in the field of gene therapy.

pic

Experienced professionals

Technical talents and resources with unique advantages in various drug R&D service fields, and the management team and PIs are from domestic/international well-known CROs or pharmaceutical companies, who are well versed in domestic and international drug R&D laws and regulations and quality systems to provide customers with high-quality research results.

pic

First-mover advantage in bioanalysis 

  

Xihua has been deeply engaged in bioanalysis since its establishment in 2015, and has accumulated rich experience in the field of bioanalysis, which makes it an industry leader in terms of business scale, quality and reputation in this segment.

pic

Wide range of customers and high stickiness 

We have accumulated rich industry experience and established a good reputation, and successfully expanded the service of providing a full range of new drug development services to large domestic and foreign pharmaceutical companies and many emerging well-known innovative biotechnology companies. Data as of June 30, 2022, the company has served nearly 600 domestic and international customers, including both most of top 50 domestic pharmaceutical companies and  the top 10 global pharmaceutical companies, as well as small and medium-sized Biotech companies.

pic

Honorary Qualification

1

Xihua Headquarters

Address:Building 5, 6 and 7, Lane 118, Furonghua Road, Pudong New Area, Shanghai

Learn more>

Business Consulting

China

Tel:+86-21-5808 6608

Email:BD@xihuasci.com

Overseas

Tel:+01-609-921-7115 (US)

Fax:   +01-609-921-7116 (US)

Other Consultations

China

Email:IR@xihuasci.com

Follow Xihua

Copyright ©.2022 Shanghai Xihua Scientific Co.,Ltd. All right reserved 沪ICP备2020032492号-1